This article is more than 5 years old. Information may no longer be current.
OSN’s top news of the week
Click Here to Manage Email Alerts
Here are some top stories on Healio.com/OSN from the past week:
EHR documentation reflects ‘paper note paradigm’
Very little content in electronic health record notes is manually entered, the notes are long and redundant, and most are not even looked at, Michael F. Chiang, MD, said at the American Association for Pediatric Ophthalmology and Strabismus annual meeting. Read more.
Improvements maintained at 4 years after Luxturna administration
Improvements in ambulatory navigation, light sensitivity and visual field continue to be maintained at 4 years of a phase 3 trial of Luxturna in patients with biallelic RPE65 mutation-associated retinal dystrophy, Arlene V. Drack, MD, said at the American Association for Pediatric Ophthalmology and Strabismus annual meeting. Read more.
Supplemental NDA accepted for Dextenza inflammation indication
The FDA has accepted a supplemental new drug application for Dextenza for the treatment of ocular inflammation following ophthalmic surgery, Ocular Therapeutix announced. Read more.
Machine learning models may facilitate clinic workflow
Exam times predicted by machine may be used to help manage clinic workflow and patient wait times, according to a speaker. Read more.
Oxurion completes phase 2 enrollment for anti-PlGF, anti-VEGF combination therapy for DME
Enrollment is complete in a phase 2 trial of the anti-PlGF THR-317 in combination with the anti-VEGF ranibizumab for the treatment of diabetic macular edema. Read more.